Anhydrol Forte 20% w/v Cutaneous Solution

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Compra

Scheda tecnica Scheda tecnica (SPC)
22-09-2016

Principio attivo:

Aluminium chloride hexahydrate

Commercializzato da:

Dermal Laboratories Ltd

Codice ATC:

D11AA

INN (Nome Internazionale):

Aluminium chloride hexahydrate

Dosaggio:

20 percent weight/volume

Forma farmaceutica:

Cutaneous solution

Tipo di ricetta:

Product not subject to medical prescription

Area terapeutica:

Antihidrotics

Stato dell'autorizzazione:

Marketed

Data dell'autorizzazione:

1982-03-15

Scheda tecnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Anhydrol Forte 20% w/v Cutaneous Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Aluminium Chloride Hexahydrate 20.0 % w/v.
For full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous solution
Clear, colourless, evaporative solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the topical treatment of hyperhidrosis specifically involving
axillae, hands or feet.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For adults, children and the elderly.
Apply to the affected sites at night, as required, and allow to dry.
Wash off in the morning.
4.3 CONTRAINDICATIONS
Not to be used in cases of sensitivity to any of the ingredients.
Not to be used in axillae within 12 hours of using depilatories or
shaving.
Not to be used immediately after bathing.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Care should be taken to restrict the application to the affected sites
only.
Keep away from the eyes and mucous membranes.
Care should be taken to avoid Anhydrol Forte coming into direct
contact with clothing, polished surfaces, jewellery or
metal.
Replace cap tightly after use.
For external use only.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Do not bathe immediately before use and, if the axillae are treated,
do not shave or use depilatories on this area within 12
hours before or after use.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_7_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_
                                
                                Leggi il documento completo